Free Trial

Bradley Woods Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Bradley Woods. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Bradley Woods' equity research team. MarketBeat is not affiliated with or endorsed by Bradley Woods.

  • Updated 2/8/2021
Average Return
00.00% 12-Month ROI
Total Ratings
0 Last 12 Months
Buy Ratings
0 Last 12 Months
Sell Ratings
0 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Vuzix Corporation stock logo
VUZI
Vuzix
$3.19
-6.5%
8/5/2020Reiterated RatingBuyView details for Bradley Woods rating of Vuzix (NASDAQ:VUZI) on 8/5/2020

MarketBeat's community ratings are surveys of what our community members think about Bradley Woods and other research firms in the last 90 days. Vote "Outperform" if you believe Bradley Woods's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Bradley Woods's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
2.5out of 5 (last 90 days)
2.5 of 5 stars
OUTPERFORM VOTES
20 Believe will outperform the market
UNDERPERFORM VOTES
20 Believe will underperform the market

Best & Worst Calls